DK200801818A - Vaccine antigens from piscirickettsia salmonis - Google Patents
Vaccine antigens from piscirickettsia salmonis Download PDFInfo
- Publication number
- DK200801818A DK200801818A DK200801818A DKPA200801818A DK200801818A DK 200801818 A DK200801818 A DK 200801818A DK 200801818 A DK200801818 A DK 200801818A DK PA200801818 A DKPA200801818 A DK PA200801818A DK 200801818 A DK200801818 A DK 200801818A
- Authority
- DK
- Denmark
- Prior art keywords
- protein
- seq
- amino acid
- vaccine
- group
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title claims 12
- 239000000427 antigen Substances 0.000 title claims 4
- 102000036639 antigens Human genes 0.000 title claims 4
- 108091007433 antigens Proteins 0.000 title claims 4
- 241000192126 Piscirickettsia salmonis Species 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 claims 28
- 102000004169 proteins and genes Human genes 0.000 claims 28
- 125000003275 alpha amino acid group Chemical group 0.000 claims 14
- 238000000034 method Methods 0.000 claims 10
- 108020004707 nucleic acids Proteins 0.000 claims 10
- 102000039446 nucleic acids Human genes 0.000 claims 10
- 150000007523 nucleic acids Chemical class 0.000 claims 10
- 239000002773 nucleotide Substances 0.000 claims 10
- 125000003729 nucleotide group Chemical group 0.000 claims 10
- 230000000890 antigenic effect Effects 0.000 claims 7
- 239000012634 fragment Substances 0.000 claims 7
- 241000251468 Actinopterygii Species 0.000 claims 6
- 239000013604 expression vector Substances 0.000 claims 6
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 5
- 241000277331 Salmonidae Species 0.000 claims 5
- 241000235058 Komagataella pastoris Species 0.000 claims 4
- 208000009663 Acute Necrotizing Pancreatitis Diseases 0.000 claims 3
- 206010058096 Pancreatic necrosis Diseases 0.000 claims 3
- 241000700605 Viruses Species 0.000 claims 3
- 208000015181 infectious disease Diseases 0.000 claims 3
- 230000002458 infectious effect Effects 0.000 claims 3
- 108020004414 DNA Proteins 0.000 claims 2
- 102000053602 DNA Human genes 0.000 claims 2
- 241000588724 Escherichia coli Species 0.000 claims 2
- 241000606651 Rickettsiales Species 0.000 claims 2
- 101100065106 Schizosaccharomyces pombe (strain 972 / ATCC 24843) egt1 gene Proteins 0.000 claims 2
- 206010040047 Sepsis Diseases 0.000 claims 2
- 238000012258 culturing Methods 0.000 claims 2
- 239000001963 growth medium Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 239000013612 plasmid Substances 0.000 claims 2
- 229920001184 polypeptide Polymers 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 208000013223 septicemia Diseases 0.000 claims 2
- 238000006467 substitution reaction Methods 0.000 claims 2
- 241000607525 Aeromonas salmonicida Species 0.000 claims 1
- 241000277334 Oncorhynchus Species 0.000 claims 1
- 241000277338 Oncorhynchus kisutch Species 0.000 claims 1
- 241000277289 Salmo salar Species 0.000 claims 1
- 241001148129 Yersinia ruckeri Species 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0233—Rickettsiales, e.g. Anaplasma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0208—Specific bacteria not otherwise provided for
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1246—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Rickettsiales (O)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1478207P | 2007-12-19 | 2007-12-19 | |
| US1478207 | 2007-12-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK200801818A true DK200801818A (en) | 2009-06-20 |
Family
ID=40471541
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK200801818A DK200801818A (en) | 2007-12-19 | 2008-12-19 | Vaccine antigens from piscirickettsia salmonis |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US7811583B2 (fr) |
| EP (1) | EP2231698B9 (fr) |
| AU (1) | AU2008337440B2 (fr) |
| CA (1) | CA2708167C (fr) |
| DK (1) | DK200801818A (fr) |
| WO (1) | WO2009077577A2 (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4381977B2 (ja) * | 2002-07-15 | 2009-12-09 | ノバルティス アクチエンゲゼルシャフト | アースロバクター細胞に基づくサケリケッチア敗血症に対するワクチン |
| WO2014118385A1 (fr) | 2013-02-04 | 2014-08-07 | University of Tromsø | Utilisation de séquences d'adn codant pour un interféron en tant qu'adjuvants de vaccin |
| CN103110583A (zh) * | 2013-03-05 | 2013-05-22 | 西南民族大学 | 一种绵羊肺炎支原体灭活疫苗的制备工艺 |
| CA2915211C (fr) * | 2013-06-14 | 2022-08-23 | Cermaq As | Nouvel isolat de piscirickettsia salmonis |
| US9580758B2 (en) | 2013-11-12 | 2017-02-28 | Luc Montagnier | System and method for the detection and treatment of infection by a microbial agent associated with HIV infection |
| EP3249041A1 (fr) * | 2014-11-24 | 2017-11-29 | Pontificia Universidad Católica De Valparaíso | Milieu de culture permettant la croissance de la bactérie piscirickettsia salmonis |
| NO20200827A1 (en) * | 2017-12-26 | 2020-07-14 | Univ Chile | Vaccine formulation for fish based on lipid nanovesicles,particularly a proteoliposome or cochleate, with activity against the salmonid rickettsial syndrome (srs) |
| WO2021247715A2 (fr) * | 2020-06-03 | 2021-12-09 | The Regents Of The University Of California | Antigènes immunogènes de francisella et leur utilisation dans l'immunisation de poissons contre la francisellose |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5165925A (en) * | 1989-05-02 | 1992-11-24 | State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University | Vaccine for immunizing fish against infectious pancreatic necrosis virus |
| DK0712926T3 (da) | 1994-10-18 | 2004-02-09 | Akzo Nobel Nv | Virus, der forårsager bugspytkirtelsygdom hos fisk |
| NO329958B1 (no) | 1999-09-17 | 2011-01-31 | Pfizer Canada Inc | Anvendelse av en immunogen mengde av OspA-lipoprotein fra Piscirickettsia salmonis, OspA-antigen, og immunogene promiskuose TCE i et OspA-kimaert fusjonsprotein, for fremstilling av medikamenter, og immunologisk in vitro-fremgangsmate for deteksjon av humoralt antistoff mot OspA eller P. salmonis. |
| US20030165526A1 (en) * | 1999-09-17 | 2003-09-04 | Kuzyk Michael A. | Vaccines and agents for inducing immunity against rickettsial diseases, and associated preventative therapy |
| WO2001049712A2 (fr) | 2000-01-07 | 2001-07-12 | Akzo Nobel N.V. | Vaccin destine a la prevention et/ou la prophylaxie de l'anemie infectieuse du saumon chez des poissons |
| EP1282710B1 (fr) * | 2000-03-11 | 2008-03-05 | Novartis AG | Vaccin contre la piscirickettsia salmonis destine aux poissons |
| ES2281437T3 (es) * | 2000-08-22 | 2007-10-01 | Agensys, Inc. | Acido nucleico y proteina correspondiente denominada 158p1d7 util para el tratamiento y la deteccion del cancer de vejiga y otros canceres. |
| DK1334197T3 (da) | 2000-11-11 | 2011-04-04 | Univ Aberdeen | Gær-afledt vaccine mod IPNV |
| WO2003013597A1 (fr) * | 2001-08-10 | 2003-02-20 | University Of Maryland Biotechnology Institute | Vaccin sous-unite pour le virus de necrose pancreatique infectieux |
| CA2381708C (fr) * | 2001-08-27 | 2011-10-18 | Universidad Catolica De Valparaiso | Proteine immunogenique contre l'infection par piscirickettsia salmonis |
| JP4381977B2 (ja) * | 2002-07-15 | 2009-12-09 | ノバルティス アクチエンゲゼルシャフト | アースロバクター細胞に基づくサケリケッチア敗血症に対するワクチン |
| CA2541464C (fr) * | 2003-10-07 | 2016-02-09 | Michel Thiry | Antigenes de piscirickettsia salmonis et leur utilisation |
| CA2615139A1 (fr) * | 2004-10-01 | 2006-04-13 | Michel Thiry | Antigenes de piscirickettsia salmonis et utilisation de ceux-ci |
-
2008
- 2008-12-18 EP EP08862540.5A patent/EP2231698B9/fr active Active
- 2008-12-18 AU AU2008337440A patent/AU2008337440B2/en not_active Ceased
- 2008-12-18 CA CA2708167A patent/CA2708167C/fr active Active
- 2008-12-18 US US12/338,192 patent/US7811583B2/en not_active Expired - Fee Related
- 2008-12-18 WO PCT/EP2008/067830 patent/WO2009077577A2/fr active Application Filing
- 2008-12-19 DK DK200801818A patent/DK200801818A/en not_active Application Discontinuation
-
2010
- 2010-09-20 US US12/886,256 patent/US20110070256A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20090162391A1 (en) | 2009-06-25 |
| WO2009077577A2 (fr) | 2009-06-25 |
| EP2231698B1 (fr) | 2014-07-30 |
| AU2008337440A1 (en) | 2009-06-25 |
| EP2231698B9 (fr) | 2014-10-29 |
| CA2708167A1 (fr) | 2009-06-25 |
| US20110070256A1 (en) | 2011-03-24 |
| US7811583B2 (en) | 2010-10-12 |
| AU2008337440B2 (en) | 2013-05-02 |
| WO2009077577A3 (fr) | 2009-09-24 |
| EP2231698A2 (fr) | 2010-09-29 |
| CA2708167C (fr) | 2016-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK200801818A (en) | Vaccine antigens from piscirickettsia salmonis | |
| EP2271663B1 (fr) | Nouvel astrovirus aviaire | |
| CN103739717B (zh) | 一种抗猪2型圆环病毒病的重组蛋白亚单位疫苗 | |
| Zhou et al. | A novel multivalent vaccine based on secretary antigen-delivery induces protective immunity against Vibrio anguillarum and Aeromonas hydrophila | |
| CN109195623A (zh) | 嵌合型猪圆环病毒2型(pcv2)疫苗 | |
| Meir et al. | Immune responses to mucosal vaccination by the recombinant S1 and N proteins of infectious bronchitis virus | |
| DK179920B1 (en) | Nucleic acid sequences of a fish virus and its use | |
| DK180623B1 (en) | Fish virus | |
| US20150306209A1 (en) | CANINE PARVOVIRUS TYPE 2c ISOLATES AND METHODS OF USE | |
| JP2009509496A (ja) | ローソニアイントラセルラリスの免疫学的タンパク | |
| CN101880647B (zh) | 重组猪霍乱沙门氏菌及二价基因工程疫苗与应用 | |
| US20100221275A1 (en) | Protection of an animal against pestivirus infection | |
| Tan et al. | Cloning, expression and protective capacity of 37 kDa outer membrane protein gene (ompH) of Pasteurella multocida serotype B: 2. | |
| EP1523497B1 (fr) | Gene hsp70 provenant du genre arthrobacter | |
| US20230190923A1 (en) | Compositions comprising ltb and pathogenic antigens, and use thereof | |
| KR102477253B1 (ko) | 강화된 조류 인플루엔자 바이러스-유사입자를 포함하는 백신 조성물 및 이의 제조 방법 | |
| CN106117365A (zh) | 抗猪链球菌病且具有自身免疫活性的融合蛋白及其制备和应用 | |
| Shao et al. | Immune potential of a novel multiple-epitope vaccine to FMDV type Asia 1 in guinea pigs and sheep | |
| Phromnoi et al. | Expression of recombinant VP2 protein of Canine parvovirus in Escherichia coli | |
| KR102451412B1 (ko) | 세포성, 체액성 면역 반응의 동시 유도 및 광범위한 방어능을 갖는 신규 면역 증강용 단백질 및 이를 포함하는 구제역 백신 조성물 | |
| DK200900603A (da) | Piscirickettsia salmonis-antigener og anvendelse deraf | |
| RU2707129C2 (ru) | СПОСОБ ПОЛУЧЕНИЯ ШТАММА Е. coli BL21 Star™(DE3) pET302/NT-His tcpA - ПРОДУЦЕНТА РЕКОМБИНАНТНОГО БЕЛКА Тср А ХОЛЕРНОГО ВИБРИОНА БИОВАРА ЭЛЬ ТОР | |
| DK200700656A (da) | Piscirickettsia salmonis-antigener og anvendelse deraf | |
| CN107245105B (zh) | HN-VP233-221aa融合蛋白及其制备方法和应用 | |
| CN107625960B (zh) | 一种通用型猪大肠杆菌病疫苗及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PHB | Application deemed withdrawn due to non-payment or other reasons |
Effective date: 20140624 |